Clobazam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401515This classification denotes an anxiolytic with the molecular formula C16H13ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2MRO291B4U, chemically known as 7-chloro-1-methyl-5-phenyl-1h-1,5-benzodiazepine-2,4(3h,5h)-dione but generally known as clobazam, which bears US NIH Compound Identifier 2789. European Medicines Agency schedules Clobazam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06673MIG. The term CLOBAZAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules clobazam in its Anatomical Therapeutic Chemical (ATC) Classification. CLOBAZAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clobazam under HS 29337200 and SITC 51561. As of Q4 2014, CLOBAZAM remains the US FDA Preferred Term for this commodity. Clobazam bears US NLM identifiers UMLS ID C0055891 and NCI Concept Code C81615. SMILES: CLC1CC2N(C(=O)CC(=O)N(C2CC1)C)C1CCCCC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.